Search - tctmd.com

Displaying 661 - 680 of 1240

Sort: Relevancy | Date

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

July 21, 2015

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

News Industry News

CryoLife Receives Expanded Indication for BioGlue® in Japan

July 09, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Industry News

Hansen Medical® Announces FDA Clearance of the Magellan™ 10Fr Robotic Catheter

July 02, 2015

News Industry News

Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency

July 02, 2015

Advertisement

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

Symic Biomedical Selects Vascular Clinical Candidate

MVARC Document Offers Template for Mitral Valve Therapeutics Research

QT Vascular Announces The Allowance Of Four New Patents

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

CryoLife Receives Expanded Indication for BioGlue® in Japan

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

Hansen Medical® Announces FDA Clearance of the Magellan™ 10Fr Robotic Catheter

Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content